🔗 Permalink

Assignee profile:

XENCOR, INC.

City:

Monrovia, California

Country:

United States

Published Applications:

247

Last publication date:

2023-08-31

Patent Grants:

175

Last grant date:

2026-02-24

Quarterly XENCOR, INC. Patent Applications

Top Inventors for applications by XENCOR, INC.

These are the the leading inventors for applications assigned to XENCOR, INC.:

John R. Desjarlais 118 Pasadena, CA United States
John Desjarlais 73 Pasadena, CA United States
Wei Dang 61 Pasadena, CA United States
Omid Vafa 61 Monrovia, CA United States

Matthew J. Bernett 48 Monrovia, CA United States
Sher Bahadur Karki 46 Pomona, CA United States
Sher Bahadur Karki 42 Pasadena, CA United States
Gregory Alan Lazar 38 Arcadia, CA United States

Gregory L. Moore 32 Monrovia, CA United States
Matthew Bernett 30 Monrovia, CA United States
Arthur J. Chirino 29 Camarillo, CA United States
Gregory Alan Lazar 28 Los Angeles, CA United States

Seung Yup Chu 25 Cypress, CA United States
Robert Hayes 24 Paoli, PA United States
Gregory Moore 24 Azusa, CA United States
Robert J. Hayes 24 Radnor, PA United States

Rumana Rashid 23 Temple City, CA United States
Sher Bahadur Karki 21 Santa Monica, CA United States
Gregory Alan Lazar 20 Alhambra, CA United States
Stephen Kohl Doberstein 17 San Francisco, CA United States

Igor Vostiar 16 Monrovia, CA United States
Bassil I. Dahiyat 16 Altadena, CA United States
Jonathan Zalevsky 15 Riverside, CA United States
Aaron Keith Chamberlain 13 Pasadena, CA United States

Jost Vielmetter 13 Altadena, CA United States
Christine Bonzon 13 Los Angeles, CA United States
Umesh Muchhal 13 Monrovia, CA United States
Stephen K. Doberstein 13 San Francisco, CA United States

Gregory Alan Lazar 12 Indianapolis, IN United States
Seung Chu 12 Cypress, CA United States
Sung-Hyung Lee 11 San Gabriel, CA United States
Seung Y. Chu 11 Cypress, CA United States

Rumana Rashid 11 Arcadia, CA United States
Gregory A. Lazar 10 Arcadia, CA United States
Philip W. Hammond 9 Sierra Madre, CA United States
Gregory Alan Lazar 9 Monrovia, CA United States

Gregory Moore 9 Arcadia, CA United States
Rajat Varma 9 Monrovia, CA United States
Holly M. Horton 8 Boston, MA United States
Michael Hedvat 8 Encino, CA United States

John O. Richards 8 Duarte, CA United States
Eugene Alexander Zhukovsky 7 West Hollywood, CA United States
David F. Carmichael 7 Monrovia, CA United States
Erik Weiking Pong 7 Temple City, CA United States

Alex Nisthal 7 Monrovia, CA United States
John Rudolph Desjarlais 6 Pasadena, CA United States
Seung Chu 6 Upland, CA United States
Duc-Hanh Thi Nguyen 6 Sylmar, CA United States

Shannon Alicia Marshall 5 San Francisco, CA United States
Umesh S. Muchhal 5 Monrovia, CA United States
Gregory A. Lazar 5 Los Angeles, CA United States
Gregory Alan Lazar 5 Pacifica, CA United States

Gregory Moore 4 Monrovia, CA United States
Gregory Lazar 4 Indianapolis, IN United States
Darian Cash 4 Los Angeles, CA United States
Robert Hayes 4 Radnor, PA United States

Bao-Lu Chen 4 San Ramon, CA United States
Seung Y. Chu 4 Upland, CA United States
Sergei A. Ezhevsky 4 San Diego, CA United States
John Desjarlais 3 Monrovia, CA United States

Jason Guu 3 Yorba Linda, CA United States
Sher Karki 3 Santa Monica, CA United States
Juan Diaz 3 Anaheim Hills, CA United States
Xencor, Inc. 3 Monrovia, CA United States

David Szymkowski 3 Monrovia, CA United States
Lesley Probert 3 Athens, Greece
Gregory Alan Lazar 3 Glendale, CA United States
Matthew Bernett 3 Pasadena, CA United States

Robert J. Hayes 3 Thousand Oaks, CA United States
Bassil I. DAHIYAT 3 Alta Dena, CA United States
GREGORY L. MOORE 3 PASADENA, CA United States
Paul Michael Steed 3 Chapel Hill, NC United States

Malu Tansey 3 Decatur, GA United States
Paul Foster 3 Rancho Santa Fe, CA United States
Aaron K. Chamberlain 3 Pasadena, CA United States
David Edmund Szymkowski 3 Monrovia, CA United States

Yanbin Liang 3 Irvine, CA United States
GREGORY LAZAR 3 PACIFICA, CA United States
Gregory A. Lazar 3 Pacifica, CA United States
Rumana Rashid 3 Azusa, CA United States

Suzanne Schubbert 3 Long Beach, CA United States
Peter C. Baciu 3 Laguna Niguel, CA United States
Bassil Dahiyat 2 Altadena, CA United States
Rene S. HUBERT 2 Los Angeles, CA United States

John J. Desjarlais 2 Pasadena, CA United States
Shannon A. Marshall 2 San Francisco, CA United States
Shigeyuki Iijima 2 Shizuoka, Japan
Gregory Moore 2 Azuza, CA United States

Dilki Wickramarachichi 2 Pasadena, CA United States
Xencor, Inc. 2 , United States
Igor Vostiar 2 Monrovia, Slovak Republic
Holly M. Horton 2 Pasadena, CA United States

Stephen Kohl Doberstein 2 Pasadena, CA United States
Aaron Keith Chamberlain 2 San Diego, CA United States
Ke Liu 2 Glendora, CA United States
Sean C. Yoder 2 Santa Monica, CA United States

Shiv Pillai 2 Monrovia, CA United States
Masamichi Sugimoto 2 Kanagawa, Japan
Bassil I. Dahiyat 2 Los Angeles, CA United States
Paul Foster 2 Monrovia, CA United States

Recent patent applications by XENCOR, INC.

XENCOR, INC. based in Monrovia, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-31 ✅ Patent 12,559,572 granted on 2026-02-24

US20230272114A1

Chemistry; metallurgy

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

#2 | 2023-04-27

US20230129938A1

Chemistry; metallurgy

METHODS OF TREATING NEUROLOGICAL DISEASES

#3 | 2023-03-09

US20230074793A1

Chemistry; metallurgy

TREATMENT WITH A BISPECIFIC ANTIBODY THAT BINDS CTLA4 AND PD1

#4 | 2023-02-16 ✅ Patent 11,987,636 granted on 2024-05-21

US20230048390A1

Chemistry; metallurgy

Dosing of a bispecific antibody that binds CD20 and CD3

#5 | 2022-12-08 ✅ Patent 12,509,518 granted on 2025-12-30

US20220389098A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

#6 | 2022-04-21 ✅ Patent 11,591,401 granted on 2023-02-28

US20220119530A1

Chemistry; metallurgy

Anti-CD28 compositions

#7 | 2021-12-23

US20210395363A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#8 | 2021-07-29 ✅ Patent 11,254,727 granted on 2022-02-22

US20210230250A1

Chemistry; metallurgy

CTLA4-Ig immunoadhesins

#9 | 2021-06-17 ✅ Patent 11,530,274 granted on 2022-12-20

US20210179731A1

Chemistry; metallurgy

Anti-STEAP1 antigen-binding protein

#10 | 2021-03-11 ✅ Patent 11,512,122 granted on 2022-11-29

US20210070824A1

Chemistry; metallurgy

IL-7-FC-fusion proteins

#11 | 2021-01-14

US20210009690A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#12 | 2021-01-14

US20210009689A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#13 | 2020-10-22 ✅ Patent 11,566,080 granted on 2023-01-31

US20200332024A1

Chemistry; metallurgy

Compositions and methods for treating IgE-mediated disorders

#14 | 2020-10-08 ✅ Patent 11,472,890 granted on 2022-10-18

US20200317814A1

Chemistry; metallurgy

Heterodimeric antibodies that bind ENPP3 and CD3

#15 | 2020-10-08 ✅ Patent 11,618,788 granted on 2023-04-04

US20200317804A1

Chemistry; metallurgy

Optimized antibodies that target CD19

#16 | 2020-08-06 ✅ Patent 11,618,776 granted on 2023-04-04

US20200247862A1

Chemistry; metallurgy

Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains

#17 | 2020-07-09 ✅ Patent 11,623,957 granted on 2023-04-11

US20200216559A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and PSMA

#18 | 2020-07-09 ✅ Patent 11,358,999 granted on 2022-06-14

US20200216509A1

Chemistry; metallurgy

IL-12 heterodimeric Fc-fusion proteins

#19 | 2020-06-25 ✅ Patent 11,352,442 granted on 2022-06-07

US20200199251A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and CD38

#20 | 2020-06-04

US20200172590A1

Chemistry; metallurgy

METHODS OF TREATING NEUROLOGICAL DISEASES

#21 | 2020-05-28 ✅ Patent 10,982,006 granted on 2021-04-20

US20200165356A1

Chemistry; metallurgy

Heterodimeric antibodies that bind fibroblast activation protein

#22 | 2020-05-07 ✅ Patent 11,377,477 granted on 2022-07-05

US20200140512A1

Chemistry; metallurgy

PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof

#23 | 2020-04-23 ✅ Patent 11,401,348 granted on 2022-08-02

US20200123274A1

Chemistry; metallurgy

Heterodimeric Fc variants

#24 | 2020-04-23 ✅ Patent 11,584,794 granted on 2023-02-21

US20200123259A1

Chemistry; metallurgy

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments

#25 | 2020-03-05

US20200071402A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#26 | 2020-02-13 ✅ Patent 11,299,554 granted on 2022-04-12

US20200048370A1

Chemistry; metallurgy

Heterodimeric proteins

#27 | 2019-12-26 ✅ Patent 11,492,407 granted on 2022-11-08

US20190389954A1

Chemistry; metallurgy

Bispecific checkpoint inhibitor antibodies

#28 | 2019-12-26 ✅ Patent 11,524,991 granted on 2022-12-13

US20190389933A1

Chemistry; metallurgy

PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof

#29 | 2019-12-19 ✅ Patent 11,236,170 granted on 2022-02-01

US20190382495A1

Chemistry; metallurgy

Bispecific checkpoint inhibitor antibodies

#30 | 2019-11-28 ✅ Patent 11,505,595 granted on 2022-11-22

US20190359684A1

Chemistry; metallurgy

TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains

#31 | 2019-10-31

US20190330342A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#32 | 2019-10-17

US20190315861A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#33 | 2019-09-05 ✅ Patent 10,981,992 granted on 2021-04-20

US20190270816A1

Chemistry; metallurgy

Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

#34 | 2019-09-05 ✅ Patent 11,053,316 granted on 2021-07-06

US20190270810A1

Chemistry; metallurgy

Optimized antibody variable regions

#35 | 2019-08-29 ✅ Patent 11,312,770 granted on 2022-04-26

US20190263909A1

Chemistry; metallurgy

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

#36 | 2019-08-15 ✅ Patent 11,225,521 granted on 2022-01-18

US20190248898A1

Chemistry; metallurgy

Heterodimeric antibodies that bind somatostatin receptor 2

#37 | 2019-08-08 ✅ Patent 11,319,355 granted on 2022-05-03

US20190241638A1

Chemistry; metallurgy

Engineered IL-2 Fc fusion proteins

#38 | 2019-07-04 ✅ Patent 11,225,528 granted on 2022-01-18

US20190202938A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#39 | 2019-06-27 ✅ Patent 11,091,548 granted on 2021-08-17

US20190194325A1

Chemistry; metallurgy

Modulation of T cells with bispecific antibodies and Fc fusions

#40 | 2019-05-02 ✅ Patent 11,352,412 granted on 2022-06-07

US20190127437A1

Chemistry; metallurgy

CTLA4-IG immunoadhesins

#41 | 2019-03-07 ✅ Patent 10,584,176 granted on 2020-03-10

US20190071512A1

Chemistry; metallurgy

Fc variants with increased affinity for FcγRIIc

#42 | 2019-01-17 ✅ Patent 11,084,863 granted on 2021-08-10

US20190016778A1

Chemistry; metallurgy

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains

#43 | 2018-10-04 ✅ Patent 10,913,803 granted on 2021-02-09

US20180282432A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#44 | 2018-08-09 ✅ Patent 11,111,315 granted on 2021-09-07

US20180223000A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#45 | 2018-08-09 ✅ Patent 10,752,678 granted on 2020-08-25

US20180222969A1

Chemistry; metallurgy

Complement component C5 antibodies

#46 | 2018-08-02 ✅ Patent 10,472,427 granted on 2019-11-12

US20180215834A1

Chemistry; metallurgy

Heterodimeric proteins

#47 | 2018-08-02

US20180215822A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#48 | 2018-08-02

US20180215821A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#49 | 2018-06-14 ✅ Patent 11,198,739 granted on 2021-12-14

US20180162950A1

Chemistry; metallurgy

Fc variants with altered binding to FcRn

#50 | 2018-05-31

US20180148511A9

Chemistry; metallurgy

OPTIMIZED ANTIBODIES THAT TARGET CD19

#51 | 2018-05-24 ✅ Patent 10,738,133 granted on 2020-08-11

US20180142040A1

Chemistry; metallurgy

Heterodimeric proteins

#52 | 2018-05-10 ✅ Patent 10,793,632 granted on 2020-10-06

US20180127501A1

Chemistry; metallurgy

Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

#53 | 2018-05-03 ✅ Patent 10,787,518 granted on 2020-09-29

US20180118836A1

Chemistry; metallurgy

Bispecific checkpoint inhibitor antibodies

#54 | 2018-05-03 ✅ Patent 10,550,185 granted on 2020-02-04

US20180118828A1

Chemistry; metallurgy

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments

#55 | 2018-05-03 ✅ Patent 10,316,088 granted on 2019-06-11

US20180118827A1

Chemistry; metallurgy

Heterodimeric antibodies that bind somatostatin receptor 2

#56 | 2018-05-03 ✅ Patent 10,501,543 granted on 2019-12-10

US20180118805A1

Chemistry; metallurgy

IL15/IL15Rα heterodimeric Fc-fusion proteins

#57 | 2018-04-05 ✅ Patent 10,858,451 granted on 2020-12-08

US20180094079A1

Chemistry; metallurgy

Bispecific antibodies that bind to CD38 and CD3

#58 | 2018-02-08 ✅ Patent 10,287,364 granted on 2019-05-14

US20180037668A1

Chemistry; metallurgy

Heterodimeric proteins

#59 | 2018-01-11 ✅ Patent 10,626,182 granted on 2020-04-21

US20180009900A1

Chemistry; metallurgy

Optimized antibodies that target CD19

#60 | 2017-12-14 ✅ Patent 11,365,256 granted on 2022-06-21

US20170355766A1

Chemistry; metallurgy

Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases

#61 | 2017-11-23 ✅ Patent 10,556,959 granted on 2020-02-11

US20170335007A1

Chemistry; metallurgy

Anti-CD39 antibodies and uses thereof

#62 | 2017-11-09 ✅ Patent 10,227,410 granted on 2019-03-12

US20170320947A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and PSMA

#63 | 2017-10-26 ✅ Patent 9,932,395 granted on 2018-04-03

US20170306007A1

Chemistry; metallurgy

Nucleic acids encoding complement component C5 antibodies

#64 | 2017-08-31

US20170247470A9

Chemistry; metallurgy

RAPID CLEARANCE OF ANTIGEN COMPLEXES USING NOVEL ANTIBODIES

#65 | 2017-03-23 ✅ Patent 9,856,327 granted on 2018-01-02

US20170081424A1

Chemistry; metallurgy

Heterodimeric antibodies to CD3 X CD123

#66 | 2017-03-23 ✅ Patent 9,850,320 granted on 2017-12-26

US20170081420A1

Chemistry; metallurgy

Heterodimeric antibodies to CD3 X CD20

#67 | 2017-02-09 ✅ Patent 10,227,411 granted on 2019-03-12

US20170037131A1

Chemistry; metallurgy

Modulation of T cells with bispecific antibodies and FC fusions

#68 | 2016-12-08 ✅ Patent 10,259,887 granted on 2019-04-16

US20160355608A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#69 | 2016-12-08 ✅ Patent 10,428,155 granted on 2019-10-01

US20160355600A1

Chemistry; metallurgy

Trispecific antibodies

#70 | 2016-12-01 ✅ Patent 10,184,000 granted on 2019-01-22

US20160347825A1

Chemistry; metallurgy

Optimized Fc variants and methods for their generation

#71 | 2016-11-24 ✅ Patent 9,663,582 granted on 2017-05-30

US20160340436A9

Chemistry; metallurgy

OPTIMIZED FC VARIANTS

#72 | 2016-11-03 ✅ Patent 10,183,999 granted on 2019-01-22

US20160318993A1

Chemistry; metallurgy

Optimized Fc variants and methods for their generation

#73 | 2016-10-20 ✅ Patent 9,657,106 granted on 2017-05-23

US20160304589A9

Chemistry; metallurgy

Optimized Fc variants

#74 | 2016-09-15 ✅ Patent 10,155,800 granted on 2018-12-18

US20160264643A1

Chemistry; metallurgy

CTLA4-Ig immunoadhesins

#75 | 2016-08-11 ✅ Patent 10,889,653 granted on 2021-01-12

US20160229924A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#76 | 2016-07-28 ✅ Patent 10,526,417 granted on 2020-01-07

US20160215063A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and CD38

#77 | 2016-06-23 ✅ Patent 9,803,023 granted on 2017-10-31

US20160176982A1

Chemistry; metallurgy

Fc variants with altered binding to FcRn

#78 | 2016-05-05

US20160122435A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

#79 | 2015-10-29 ✅ Patent 9,822,186 granted on 2017-11-21

US20150307629A1

Chemistry; metallurgy

Bispecific antibodies that bind to CD38 and CD3

#80 | 2015-08-27 ✅ Patent 9,701,743 granted on 2017-07-11

US20150239966A1

Chemistry; metallurgy

Complement component C5 antibodies

#81 | 2015-08-27 ✅ Patent 11,365,229 granted on 2022-06-21

US20150239951A1

Chemistry; metallurgy

Methods of treating neurological diseases

#82 | 2015-08-20 ✅ Patent 10,113,001 granted on 2018-10-30

US20150232567A1

Chemistry; metallurgy

Fc variants with increased affinity for FcyRIIc

#83 | 2015-07-09 ✅ Patent 10,336,818 granted on 2019-07-02

US20150191533A1

Chemistry; metallurgy

Fc variants with altered binding to FcRn

#84 | 2015-05-21 ✅ Patent 9,221,916 granted on 2015-12-29

US20150139985A1

Chemistry; metallurgy

Compositions and methods for treating IgE-mediated disorders

#85 | 2015-04-09 ✅ Patent 10,118,959 granted on 2018-11-06

US20150098941A1

Chemistry; metallurgy

Anti-glypican-3 antibody

#86 | 2015-04-02 ✅ Patent 9,266,966 granted on 2016-02-23

US20150093379A1

Chemistry; metallurgy

Compositions and methods for treating IgE-mediated disorders

#87 | 2015-03-19 ✅ Patent 9,193,798 granted on 2015-11-24

US20150079082A1

Chemistry; metallurgy

Optimized Fc variants and methods for their generation

#88 | 2015-02-05 ✅ Patent 9,914,778 granted on 2018-03-13

US20150037322A1

Chemistry; metallurgy

Methods and compositions for inhibiting CD32B expressing cells

#89 | 2015-02-05 ✅ Patent 9,902,773 granted on 2018-02-27

US20150037321A1

Chemistry; metallurgy

Methods and compositions for inhibiting CD32b expressing cells

#90 | 2015-01-08 ✅ Patent 9,663,582 granted on 2017-05-30

US20150010543A1

Chemistry; metallurgy

Optimized Fc variants

#91 | 2014-12-25 ✅ Patent 10,131,710 granted on 2018-11-20

US20140377270A1

Chemistry; metallurgy

Optimized antibody variable regions

#92 | 2014-12-25 ✅ Patent 9,714,282 granted on 2017-07-25

US20140377256A1

Chemistry; metallurgy

Optimized Fc variants and methods for their generation

#93 | 2014-12-18

US20140370021A1

Chemistry; metallurgy

OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION

#94 | 2014-12-18 ✅ Patent 10,738,132 granted on 2020-08-11

US20140370013A1

Chemistry; metallurgy

Heterodimeric proteins

#95 | 2014-12-11 ✅ Patent 10,858,417 granted on 2020-12-08

US20140363426A1

Chemistry; metallurgy

Heterodimeric proteins

#96 | 2014-12-04 ✅ Patent 10,106,624 granted on 2018-10-23

US20140356381A1

Chemistry; metallurgy

Heterodimeric proteins

#97 | 2014-10-30 ✅ Patent 10,487,155 granted on 2019-11-26

US20140322217A1

Chemistry; metallurgy

Heterodimeric proteins

#98 | 2014-10-09 ✅ Patent 10,968,276 granted on 2021-04-06

US20140302064A1

Chemistry; metallurgy

Optimized anti-CD3 variable regions

#99 | 2014-10-02 ✅ Patent 10,519,242 granted on 2019-12-31

US20140294836A1

Chemistry; metallurgy

Targeting regulatory T cells with heterodimeric proteins

#100 | 2014-10-02

US20140294835A1

Chemistry; metallurgy

NOVEL HETERODIMERIC PROTEINS

Also check out Xencor, Inc.'s (Monrovia, United States) applicant profile with 123 patent applications submitted.

AssigneeID:

12684 ⎘